End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-20 pm EDT
|
5-day change
|
1st Jan Change
|
5.63
CNY
|
-1.57%
|
|
+1.08%
|
-50.18%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,971
|
3,096
|
4,507
|
17,128
|
9,274
|
9,180
|
Enterprise Value (EV)
1 |
3,518
|
3,645
|
4,981
|
17,093
|
9,355
|
9,044
|
P/E ratio
|
130
x
|
-9.85
x
|
96.5
x
|
-64.8
x
|
-52.5
x
|
-53.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.44
x
|
1.18
x
|
1.65
x
|
4.42
x
|
14.5
x
|
16.6
x
|
EV / Revenue
|
1.71
x
|
1.38
x
|
1.82
x
|
4.41
x
|
14.7
x
|
16.4
x
|
EV / EBITDA
|
28.9
x
|
-210
x
|
58.2
x
|
119
x
|
-4.82
x
|
-45.5
x
|
EV / FCF
|
-17.2
x
|
-6.04
x
|
22.1
x
|
-136
x
|
-7.9
x
|
93.5
x
|
FCF Yield
|
-5.83%
|
-16.5%
|
4.52%
|
-0.73%
|
-12.7%
|
1.07%
|
Price to Book
|
3.29
x
|
5.24
x
|
2.85
x
|
8.6
x
|
5.79
x
|
7.27
x
|
Nbr of stocks (in thousands)
|
571,300
|
571,300
|
778,414
|
944,217
|
883,239
|
812,367
|
Reference price
2 |
5.200
|
5.420
|
5.790
|
18.14
|
10.50
|
11.30
|
Announcement Date
|
4/18/19
|
4/16/20
|
4/26/21
|
4/25/22
|
4/27/23
|
4/25/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,061
|
2,635
|
2,739
|
3,877
|
637.6
|
551.3
|
EBITDA
1 |
121.7
|
-17.32
|
85.61
|
143.2
|
-1,941
|
-198.7
|
EBIT
1 |
48.26
|
-71.95
|
49.69
|
84.57
|
-2,011
|
-248.4
|
Operating Margin
|
2.34%
|
-2.73%
|
1.81%
|
2.18%
|
-315.43%
|
-45.06%
|
Earnings before Tax (EBT)
1 |
44.07
|
-271
|
59.64
|
-201
|
-2,169
|
-195.7
|
Net income
1 |
24.47
|
-314
|
33.38
|
-226.8
|
-184.8
|
-176.4
|
Net margin
|
1.19%
|
-11.92%
|
1.22%
|
-5.85%
|
-28.99%
|
-31.99%
|
EPS
2 |
0.0400
|
-0.5500
|
0.0600
|
-0.2800
|
-0.2000
|
-0.2100
|
Free Cash Flow
1 |
-205
|
-603
|
225.3
|
-125.3
|
-1,185
|
96.74
|
FCF margin
|
-9.95%
|
-22.88%
|
8.22%
|
-3.23%
|
-185.82%
|
17.55%
|
FCF Conversion (EBITDA)
|
-
|
-
|
263.18%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
675.06%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/18/19
|
4/16/20
|
4/26/21
|
4/25/22
|
4/27/23
|
4/25/24
|
Fiscal Period: December |
2022 Q1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
-4.039
|
Net margin
|
-
|
EPS
2 |
-0.004300
|
Dividend per Share
|
-
|
Announcement Date
|
4/28/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
547
|
548
|
474
|
-
|
81.4
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
35.2
|
-
|
136
|
Leverage (Debt/EBITDA)
|
4.496
x
|
-31.66
x
|
5.538
x
|
-
|
-0.0419
x
|
-
|
Free Cash Flow
1 |
-205
|
-603
|
225
|
-125
|
-1,185
|
96.7
|
ROE (net income / shareholders' equity)
|
3.36%
|
-36.3%
|
4%
|
-10.9%
|
-115%
|
-12.4%
|
ROA (Net income/ Total Assets)
|
1.24%
|
-2.01%
|
1.32%
|
1.68%
|
-38.5%
|
-6.03%
|
Assets
1 |
1,966
|
15,639
|
2,529
|
-13,526
|
480.4
|
2,927
|
Book Value Per Share
2 |
1.580
|
1.030
|
2.030
|
2.110
|
1.810
|
1.550
|
Cash Flow per Share
2 |
0.6200
|
0.1600
|
0.1300
|
0.4400
|
0.5000
|
0.2500
|
Capex
1 |
62.5
|
76.1
|
38.6
|
71.7
|
74
|
16.7
|
Capex / Sales
|
3.03%
|
2.89%
|
1.41%
|
1.85%
|
11.6%
|
3.03%
|
Announcement Date
|
4/18/19
|
4/16/20
|
4/26/21
|
4/25/22
|
4/27/23
|
4/25/24
|
|
1st Jan change
|
Capi.
|
---|
| -50.18% | 642M | | +4.85% | 105B | | -5.99% | 62.52B | | +72.86% | 49.08B | | +15.33% | 38.99B | | +5.57% | 32.59B | | +14.13% | 20.6B | | +12.59% | 17.19B | | +18.15% | 15.13B | | +3.29% | 14.36B |
Other Commodity Chemicals
|